Annual EBIT
-$243.72 M
-$23.77 M-10.80%
December 31, 2023
Summary
- As of February 8, 2025, RCKT annual earnings before interest & taxes is -$243.72 million, with the most recent change of -$23.77 million (-10.80%) on December 31, 2023.
- During the last 3 years, RCKT annual EBIT has fallen by -$111.57 million (-84.42%).
- RCKT annual EBIT is now -4069.72% below its all-time high of -$5.84 million, reached on December 31, 2012.
Performance
RCKT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$66.25 M
+$2.93 M+4.23%
September 30, 2024
Summary
- As of February 8, 2025, RCKT quarterly earnings before interest & taxes is -$66.25 million, with the most recent change of +$2.93 million (+4.23%) on September 30, 2024.
- Over the past year, RCKT quarterly EBIT has dropped by -$4.82 million (-7.84%).
- RCKT quarterly EBIT is now -6605.26% below its all-time high of -$988.00 thousand, reached on March 31, 2015.
Performance
RCKT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$256.20 M
-$4.82 M-1.92%
September 30, 2024
Summary
- As of February 8, 2025, RCKT TTM earnings before interest & taxes is -$256.20 million, with the most recent change of -$4.82 million (-1.92%) on September 30, 2024.
- Over the past year, RCKT TTM EBIT has dropped by -$4.33 million (-1.72%).
- RCKT TTM EBIT is now -14751.94% below its all-time high of -$1.73 million, reached on December 31, 2013.
Performance
RCKT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
RCKT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.8% | -7.8% | -1.7% |
| 3 y3 years | -84.4% | -7.8% | -1.7% |
| 5 y5 years | -251.8% | -7.8% | -1.7% |
RCKT EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -49.4% | at low | -58.0% | +4.2% | -57.0% | at low |
| 5 y | 5-year | -241.8% | at low | -257.9% | +4.2% | -256.4% | at low |
| alltime | all time | -4069.7% | at low | -6605.3% | +4.2% | <-9999.0% | at low |
Rocket Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$66.25 M(-4.2%) | -$256.20 M(+1.9%) |
| Jun 2024 | - | -$69.17 M(+12.3%) | -$251.38 M(+1.6%) |
| Mar 2024 | - | -$61.58 M(+4.0%) | -$247.44 M(+1.5%) |
| Dec 2023 | -$243.72 M(+10.8%) | -$59.19 M(-3.6%) | -$243.72 M(-3.2%) |
| Sep 2023 | - | -$61.43 M(-5.8%) | -$251.87 M(+1.7%) |
| Jun 2023 | - | -$65.23 M(+12.7%) | -$247.57 M(+5.0%) |
| Mar 2023 | - | -$57.87 M(-14.1%) | -$235.88 M(+7.2%) |
| Dec 2022 | -$219.95 M(+34.8%) | -$67.34 M(+17.9%) | -$219.95 M(+12.5%) |
| Sep 2022 | - | -$57.13 M(+6.7%) | -$195.60 M(+4.4%) |
| Jun 2022 | - | -$53.54 M(+27.7%) | -$187.31 M(+12.0%) |
| Mar 2022 | - | -$41.94 M(-2.4%) | -$167.31 M(+2.5%) |
| Dec 2021 | -$163.18 M(+23.5%) | -$42.98 M(-12.0%) | -$163.18 M(-8.9%) |
| Sep 2021 | - | -$48.84 M(+45.6%) | -$179.20 M(+14.0%) |
| Jun 2021 | - | -$33.55 M(-11.3%) | -$157.23 M(+7.1%) |
| Mar 2021 | - | -$37.81 M(-35.9%) | -$146.81 M(+11.1%) |
| Dec 2020 | -$132.15 M(+85.3%) | -$59.00 M(+119.6%) | -$132.09 M(+44.2%) |
| Sep 2020 | - | -$26.87 M(+16.2%) | -$91.60 M(+11.0%) |
| Jun 2020 | - | -$23.13 M(+0.2%) | -$82.55 M(+7.4%) |
| Mar 2020 | - | -$23.09 M(+24.7%) | -$76.87 M(+7.0%) |
| Dec 2019 | -$71.31 M | -$18.51 M(+3.9%) | -$71.88 M(-9.5%) |
| Sep 2019 | - | -$17.82 M(+2.1%) | -$79.45 M(+3.8%) |
| Jun 2019 | - | -$17.45 M(-3.6%) | -$76.55 M(+4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$18.09 M(-30.7%) | -$73.50 M(+6.0%) |
| Dec 2018 | -$69.28 M(+167.3%) | -$26.09 M(+75.0%) | -$69.34 M(+23.3%) |
| Sep 2018 | - | -$14.91 M(+3.5%) | -$56.24 M(+17.0%) |
| Jun 2018 | - | -$14.40 M(+3.4%) | -$48.05 M(+30.0%) |
| Mar 2018 | - | -$13.93 M(+7.2%) | -$36.98 M(+43.7%) |
| Dec 2017 | -$25.92 M(-37.5%) | -$12.99 M(+93.3%) | -$25.73 M(+3.7%) |
| Sep 2017 | - | -$6.72 M(+102.0%) | -$24.81 M(-13.5%) |
| Jun 2017 | - | -$3.33 M(+24.3%) | -$28.69 M(-15.7%) |
| Mar 2017 | - | -$2.68 M(-77.8%) | -$34.05 M(-17.8%) |
| Dec 2016 | -$41.44 M(-37.9%) | -$12.08 M(+13.9%) | -$41.44 M(+10.4%) |
| Sep 2016 | - | -$10.60 M(+22.1%) | -$37.53 M(-54.6%) |
| Jun 2016 | - | -$8.68 M(-13.7%) | -$82.69 M(+9.0%) |
| Mar 2016 | - | -$10.07 M(+23.2%) | -$75.83 M(+13.6%) |
| Dec 2015 | -$66.75 M(+680.6%) | -$8.17 M(-85.3%) | -$66.75 M(+10.4%) |
| Sep 2015 | - | -$55.77 M(+2959.2%) | -$60.48 M(+781.9%) |
| Jun 2015 | - | -$1.82 M(+84.5%) | -$6.86 M(-10.2%) |
| Mar 2015 | - | -$988.00 K(-48.1%) | -$7.63 M(-10.7%) |
| Dec 2014 | -$8.55 M(+27.0%) | -$1.90 M(-11.2%) | -$8.55 M(+2.1%) |
| Sep 2014 | - | -$2.14 M(-17.5%) | -$8.37 M(+34.4%) |
| Jun 2014 | - | -$2.60 M(+36.4%) | -$6.23 M(+71.6%) |
| Mar 2014 | - | -$1.91 M(+10.4%) | -$3.63 M(+110.4%) |
| Dec 2013 | -$6.73 M(+15.2%) | -$1.73 M | -$1.73 M |
| Dec 2012 | -$5.84 M | - | - |
FAQ
- What is Rocket Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals annual EBIT year-on-year change?
- What is Rocket Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals quarterly EBIT year-on-year change?
- What is Rocket Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals TTM EBIT year-on-year change?
What is Rocket Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of RCKT is -$243.72 M
What is the all time high annual EBIT for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high annual earnings before interest & taxes is -$5.84 M
What is Rocket Pharmaceuticals annual EBIT year-on-year change?
Over the past year, RCKT annual earnings before interest & taxes has changed by -$23.77 M (-10.80%)
What is Rocket Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of RCKT is -$66.25 M
What is the all time high quarterly EBIT for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$988.00 K
What is Rocket Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, RCKT quarterly earnings before interest & taxes has changed by -$4.82 M (-7.84%)
What is Rocket Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of RCKT is -$256.20 M
What is the all time high TTM EBIT for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high TTM earnings before interest & taxes is -$1.73 M
What is Rocket Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, RCKT TTM earnings before interest & taxes has changed by -$4.33 M (-1.72%)